0

Dyslipidemia Collection
 181-200 of 341 Articles
Articles |  1 February 1989
Low-Density Lipoprotein e (LDL) Distribution Shown by 99mTechnetium-LDL Imaging in Patients with Myeloproliferative Diseases
Shankar Vallabhajosula, PhD; Harriet S. Gilbert, MD; Stanley J. Goldsmith, MD; et al.
Ann Intern Med. 1989;110(3):208-213. doi:10.7326/0003-4819-110-3-208
Articles |  15 September 1988
Effects of a Low Saturated Fat, Low Cholesterol Fish Oil Supplement in Hypertriglyceridemic Patients: A Placebo-Controlled Trial
William S. Harris, PhD; Carlos A. Dujovne, MD; Marjorie Zucker, MD; et al.
Ann Intern Med. 1988;109(6):465-470. doi:10.7326/0003-4819-109-6-465
Articles |  1 July 1988
Combination Drug Therapy for Familial Combined Hyperlipidemia
Cara East, MD; David W. Bilheimer, MD; Scott M. Grundy, MD, PhD
Ann Intern Med. 1988;109(1):25-32. doi:10.7326/0003-4819-109-1-25
Articles |  1 May 1988
Adverse Metabolic Effect of Omega-3 Fatty Acids in Non-Insulin-Dependent Diabetes Mellitus
HARRY GLAUBER, M.D.; PENNY WALLACE, R.N., M.S.N.; KAY GRIVER, R.D.; et al.
Ann Intern Med. 1988;108(5):663-668. doi:10.7326/0003-4819-108-5-663
Brief Communications |  1 February 1988
Lipids and Lipoprotein Changes After Heart and Liver Transplantation in a Patient with Homozygous Familial Hypercholesterolemia
P. VALDIVIELSO, M.D.; J. L. ESCOLAR, M.D.; V. CUERVAS-MONS, M.D.; et al.
Ann Intern Med. 1988;108(2):204-206. doi:10.7326/0003-4819-108-2-204
Ideas and Opinions |  1 December 1987
Prophylaxis of Atherosclerosis with Marine Omega-3 Fatty Acids: A Comprehensive Strategy
CLEMENS VON SCHACKY, M. D.
Ann Intern Med. 1987;107(6):890-899. doi:10.7326/0003-4819-107-6-890
Articles |  1 November 1987
Lovastatin (Mevinolin) in the Treatment of Heterozygous Familial Hypercholesterolemia: A Multicenter Study
RICHARD J. HAVEL, M.D.; DONALD B. HUNNINGHAKE, M.D.; D. ROGER ILLINGWORTH, M.D., Ph.D.; et al.
Ann Intern Med. 1987;107(5):609-615. doi:10.7326/0003-4819-107-5-609
Articles |  1 November 1987
Complementarity of Colestipol, Niacin, and Lovastatin in Treatment of Severe Familial Hypercholesterolemia
MARY J. MALLOY, M.D.; JOHN P. KANE, M.D., Ph.D.; STEVEN T. KUNITAKE, Ph.D.; et al.
Ann Intern Med. 1987;107(5):616-623. doi:10.7326/0003-4819-107-5-616
Editorials |  1 November 1987
3-Hydroxy-3-methylglutaryl Coenzyme A (HMG-CoA) Reductase Inhibitors: A New Class of Cholesterol-Lowering Agents
DAVID J. GORDON, M.D., Ph.D.; BASIL M. RIFKIND, M.D.
Ann Intern Med. 1987;107(5):759-761. doi:10.7326/0003-4819-107-5-759
Articles |  1 September 1987
Alterations in Serum Thyroid Hormonal Indices with Colestipol-Niacin Therapy
LINDA CASHIN-HEMPHILL, M.D.; CAROLE A. SPENCER, Ph.D.; JOHN T. NICOLOFF, M.D.; et al.
Ann Intern Med. 1987;107(3):324-329. doi:10.7326/0003-4819-107-2-324
Brief Reports |  1 July 1987
Pancreatitis Associated with Isotretinoin-lnduced Hypertriglyceridemia
WILLIAM J. FLYNN, M.D.; PAMELA G. FREEMAN, M.D.; LLOYD G. WICKBOLDT, M.D.
Ann Intern Med. 1987;107(1):63. doi:10.7326/0003-4819-107-1-63
Ideas and Opinions |  1 July 1987
United Sciences of America, Incorporated: An "Optimal" Diet?
ELEANOR A. YOUNG, Ph.D., R.D./LD.; STEVEN SCHENKER, M.D.; ELLIOT WESER, M.D.
Ann Intern Med. 1987;107(1):101-103. doi:10.7326/0003-4819-107-1-101
Medicine and Public Policy |  1 April 1987
Cholesterol Reduction and Life Expectancy: A Model Incorporating Multiple Risk Factors
WILLIAM C. TAYLOR, M.D.; THEODORE M. PASS, Ph.D.; DONALD S. SHEPARD, Ph.D.; et al.
Ann Intern Med. 1987;106(4):605-614. doi:10.7326/0003-4819-106-4-605
Brief Communications |  1 December 1986
Increased Risk for Vitamin A Toxicity in Severe Hypertriglyceridemia
JEROME K. ELLIS, B.S.; ROBERT M. RUSSELL, M.D.; FREDERICK L. MAKRAUER, M.D.; et al.
Ann Intern Med. 1986;105(6):877-879. doi:10.7326/0003-4819-105-6-877
Academia and the Profession |  1 June 1986
Computer-Assisted Design of Studies Using Routine Clinical Data: Analyzing the Association of Prednisone and Cholesterol
ROBERT L. BLUM, M.D., Ph.D.
Ann Intern Med. 1986;104(6):858-868. doi:10.7326/0003-4819-104-6-858
Articles |  1 September 1985
Influence of Combined Therapy with Mevinolin and Interruption of Bile-Acid Reabsorption on Low Density Lipoproteins in Heterozygous Familial Hypercholesterolemia
SCOTT M. GRUNDY, M.D., Ph.D.; GLORIA LENA VEGA, Ph.D.; DAVID W. BILHEIMER, M.D.
Ann Intern Med. 1985;103(3):339-343. doi:10.7326/0003-4819-103-3-339
Ideas and Opinions |  1 June 1985
Gypsies and American Medical Care
JAMES D. THOMAS, M.D.
Ann Intern Med. 1985;102(6):842-845. doi:10.7326/0003-4819-102-6-842
Articles |  1 November 1984
Mevinolin Plus Colestipol in Therapy for Severe Heterozygous Familial Hypercholesterolemia
D. ROGER ILLINGWORTH, M.D., Ph.D.
Ann Intern Med. 1984;101(5):598-604. doi:10.7326/0003-4819-101-5-598
Brief Reports |  1 June 1984
Hypercholesterolemia Persisting After Distal Ileal Bypass: Response to Mevinolin
D. ROGER ILLINGWORTH, M.D., Ph.D.; WILLIAM E. CONNOR, M.D.
Ann Intern Med. 1984;100(6):850-851. doi:10.7326/0003-4819-100-6-850
Articles |  1 April 1984
Probucol with Colestipol in the Treatment of Hypercholesterolemia
CARLOS A. DUJOVNE, M.D.; PATRICIA KREHBIEL, R.N.; SUSAN DECOURSEY, R.N., B.S.N.; et al.
Ann Intern Med. 1984;100(4):477-482. doi:10.7326/0003-4819-100-4-477
Advertisement

Buy This Article

to gain full access to the content and tools.

Want to Subscribe?

Learn more about subscription options

Forgot your password?
Enter your username and email address. We'll send you a reminder to the email address on record.
(Required)
(Required)